Stockscreener 앱 받기
23.71
0.81%
0.19
시간 외 거래:
23.71
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - Yahoo Finance
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings? - MSN
Adma Biologics (ADMA) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know - MSN
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down - The Globe and Mail
Has ADMA Biologics (ADMA) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Why ADMA Biologics, Inc. (ADMA) Surged on Monday - MSN
The Zacks Analyst Blog Highlights ADMA, FirstCash, Stride, Life Time Group and National Fuel Gas - Yahoo Finance
These 5 Buy-Ranked Mid-Cap Stocks Are Flying High Year to Date - The Globe and Mail
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times
ADMA Biologics Q1 2025 Earnings: Key Financial Updates Coming May 7 for Growing Biopharmaceutical Leader - Stock Titan
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
ADMA Biologics (ADMA) Achieves Key FDA Approval for Production B - GuruFocus
ADMA Biologics (ADMA) Attracts Hedge Fund Attention Amid Takeover Speculation - GuruFocus
ADMA Biologics stock soars to all-time high of $24.02 By Investing.com - Investing.com South Africa
ADMA Biologics (ADMA) Gains FDA Approval for Yield Enhancement P - GuruFocus
Sector Update: Health Care Stocks Swing Between Small Gains, Losses - marketscreener.com
Noteworthy Monday Option Activity: ADMA, MAR, HUM - Nasdaq
Sector Update: Health Care - marketscreener.com
What's Going On With ADMA Stock Monday?ADMA Biologics (NASDAQ:ADMA) - Benzinga
ADMA Biologics stock soars to all-time high of $24.02 - Investing.com
Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday - Benzinga
Adma Biologics Announces U.S. Fda Approval of Innovative Production Yield Enhancement Process - marketscreener.com
FDA Approves ADMA Biologics' Innovative Production Yield Enhancement Process - Nasdaq
ADMA Biologics Receives FDA Approval for Innovative Yield Enhancement Process, Paving the Way for Increased Production Capacity and Revenue Growth - Nasdaq
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process - Bluefield Daily Telegraph
ADMA Biologics Achieves Industry First: FDA Green Lights Revolutionary 20% Plasma Yield Enhancement - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
20 Takeover Rumors Hedge Funds Are Buying - Insider Monkey
ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying - MSN
10 Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
Is ADMA Biologics, Inc. (ADMA) the Best Multibagger Stock to Buy According to Billionaires? - Insider Monkey
Adma Biologics (ADMA) Gains But Lags Market: What You Should Know - Yahoo
Why ADMA Biologics Inc. (ADMA) Performed Worst On Monday? - Insider Monkey
0.39%
3.66%
자본화:
|
볼륨(24시간):